they all ready have a marketing department ready to go on the new drugs, without out funds it would go no where,they have dough coming out of everywhere now $9.2 million on a over allotment of shares. it would seem big investors are very much involved. it traded almost half its float yesterday!
It should actually be the opposite of what you say. If investors fund the company at a price of 1,50 USD, those investors with this little bit of more (inside) knowledge of the company seem this is a good deal for them. Anything they can buy below 1,50 USD should be even a better deal for them so IMO 1,50 will soon be the floor of this stock. Once disappointed investors have left the station that is...